LOS ANGELES, Dec 14 (Reuters) - Amgen Inc (AMGN.O:
Quote,
Profile,
Research) said on Friday that osteoporosis drug denosumab, the biotechnology company's most important new offering, increased bone strength in women receiving hormone therapy for breast cancer.
Source:
http://www.reuters.com/article/healt...34456620071217